Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jody Short

Vascular Neurology Springfield, OH Doctor of Osteopathy

NPI 1053527523 CMS profile 2081

200 Medical Center Dr Ste A, Springfield, OH 45504

Open in the dashboard

General payments

$5,269

54 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jody Short of Springfield, OH is reported in the CMS Open Payments database as having received $5,269 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $87 2
2024 General $109 2
2023 General $110 4
2022 General $385 15
2021 General $456 20
2020 General $58 5
2019 General $4,065 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jody Short
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Jody Short were reported at $87. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Jody Short Vascular Neurology median Middle half National median
2019 $4,065 $263 $102–$1,640 $163
2020 $58 $153 $45–$1,000 $114
2021 $456 $261 $100–$1,355 $132
2022 $385 $242 $87–$1,273 $149
2023 $110 $322 $97–$1,266 $160
2024 $109 $247 $70–$1,053 $164
2025 $87 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $4,000 1 payment
  2. Penumbra, Inc. $929 46 payments
  3. Imperative Care, INc $183 4 payments
  4. AbbVie, Inc. $122 1 payment
  5. Cordis US Corp. $22 1 payment
  6. Medtronic USA, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $4,000 1 payment
  2. Food and Beverage $1,269 53 payments
Products named General payments · program years 2019–2025
  1. Emboshield NAV6 system $4,000 1 payment
  2. Penumbra System Neurointervention $383 18 payments
  3. Benchmark $195 9 payments
  4. ZOOM 88-T LARGE DISTAL PLATFORM $183 4 payments
  5. UBRELVY $122 1 payment
  6. RED 72 $121 4 payments
  7. Penumbra System Neurointervention $56 2 payments
  8. POD Peripheral Intervention $56 3 payments
  9. 3D Revascularization $37 3 payments
  10. POD Peripheral Intervention $36 3 payments
  11. Other $92 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$33,814

Medicare's payments for the services billed

Medicare patients

38

Average age 74

Services billed

149

15 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 55%
Diabetes 47%
Arthritis 45%
COPD 39%
Heart failure 32%
Atrial fibrillation 32%
Depression 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record